Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates - PubMed (original) (raw)
doi: 10.1093/jac/dkt315. Epub 2013 Aug 29.
Affiliations
- PMID: 23997018
- DOI: 10.1093/jac/dkt315
Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates
Myung-Jin Choi et al. J Antimicrob Chemother. 2014 Jan.
No abstract available
Keywords: MSW; mutant selection window; polymyxins; two-component systems.
Similar articles
- Mutant prevention concentrations of colistin used in combination with other antimicrobial agents against Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa clinical isolates.
Choi MJ, Park YK, Peck KR, Ko KS. Choi MJ, et al. Int J Antimicrob Agents. 2014 Nov;44(5):475-6. doi: 10.1016/j.ijantimicag.2014.07.015. Int J Antimicrob Agents. 2014. PMID: 25443890 No abstract available. - In-vitro bactericidal activity of colistin against biofilm-associated Pseudomonas aeruginosa and Acinetobacter baumannii.
Cai Y, Wang R, Liang BB, An MM. Cai Y, et al. J Hosp Infect. 2009 Aug;72(4):368-70. doi: 10.1016/j.jhin.2009.03.013. Epub 2009 May 13. J Hosp Infect. 2009. PMID: 19443079 No abstract available. - Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients.
Falagas ME, Rafailidis PI, Matthaiou DK, Virtzili S, Nikita D, Michalopoulos A. Falagas ME, et al. Int J Antimicrob Agents. 2008 Nov;32(5):450-4. doi: 10.1016/j.ijantimicag.2008.05.016. Epub 2008 Sep 2. Int J Antimicrob Agents. 2008. PMID: 18768302 - Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis.
Vardakas KZ, Voulgaris GL, Samonis G, Falagas ME. Vardakas KZ, et al. Int J Antimicrob Agents. 2018 Jan;51(1):1-9. doi: 10.1016/j.ijantimicag.2017.05.016. Epub 2017 Jun 29. Int J Antimicrob Agents. 2018. PMID: 28669836 Review. - Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology.
Potron A, Poirel L, Nordmann P. Potron A, et al. Int J Antimicrob Agents. 2015 Jun;45(6):568-85. doi: 10.1016/j.ijantimicag.2015.03.001. Epub 2015 Mar 24. Int J Antimicrob Agents. 2015. PMID: 25857949 Review.
Cited by
- Keeping up with the pathogens: improved antimicrobial resistance detection and prediction from Pseudomonas aeruginosa genomes.
Madden DE, Baird T, Bell SC, McCarthy KL, Price EP, Sarovich DS. Madden DE, et al. Genome Med. 2024 Jun 7;16(1):78. doi: 10.1186/s13073-024-01346-z. Genome Med. 2024. PMID: 38849863 Free PMC article. - The Role of Colistin in the Era of New β-Lactam/β-Lactamase Inhibitor Combinations.
Aslan AT, Akova M. Aslan AT, et al. Antibiotics (Basel). 2022 Feb 20;11(2):277. doi: 10.3390/antibiotics11020277. Antibiotics (Basel). 2022. PMID: 35203879 Free PMC article. Review. - Global colistin use: a review of the emergence of resistant Enterobacterales and the impact on their genetic basis.
Binsker U, Käsbohrer A, Hammerl JA. Binsker U, et al. FEMS Microbiol Rev. 2022 Feb 9;46(1):fuab049. doi: 10.1093/femsre/fuab049. FEMS Microbiol Rev. 2022. PMID: 34612488 Free PMC article. Review. - Current Update on Intrinsic and Acquired Colistin Resistance Mechanisms in Bacteria.
Gogry FA, Siddiqui MT, Sultan I, Haq QMR. Gogry FA, et al. Front Med (Lausanne). 2021 Aug 12;8:677720. doi: 10.3389/fmed.2021.677720. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34476235 Free PMC article. Review. - Polymyxins, the last-resort antibiotics: Mode of action, resistance emergence, and potential solutions.
Mohapatra SS, Dwibedy SK, Padhy I. Mohapatra SS, et al. J Biosci. 2021;46(3):85. doi: 10.1007/s12038-021-00209-8. J Biosci. 2021. PMID: 34475315 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical